Health-related quality of life burden in scleroderma patients treated with two different intravenous iloprost regimens. Reumatismo [Internet]. 2019 Jul. 9 [cited 2026 Jul. 20];71(2):62-7. Available from: https://www.reumatismo.org/reuma/article/view/1190